Apidra U/ml, solution for injection in a pre filled pen SoloStar. 2. the pre- filled pen SoloStar, the instructions for use included in the package leaflet must. Apidra SoloStar Units/ml solution for injection in a pre-filled pen . SoloStar, the Instructions for use included in the Package leaflet must be read carefully. Package leaflet: Information for the user. Apidra® SoloStar®. Units/ml solution for injection in a pre-filled pen insulin glulisine. Talk to your doctor.
|Published (Last):||5 December 2013|
|PDF File Size:||4.67 Mb|
|ePub File Size:||5.67 Mb|
|Price:||Free* [*Free Regsitration Required]|
What is in this leaflet This leaflet answers some common questions about Apidra.
Apidra (insulin glulisine) Drug / Medicine Information
Although apidra package insert data are available and the drug has been used as an intravenous infusion in healthy subjects, dosage information for the treatment of hyperglycemia is not available. While pharmacokinetic data are packags and the drug has been used as an intravenous infusion in healthy subjects, dosage information for the treatment of hyperglycemia is not available.
Certain heart medications, especially beta-blockers, may mask the symptoms of hypoglycaemia. Patients should be monitored for worsening of glycemic control if therapy with tacrolimus is initiated in patients receiving antidiabetic agents. Monitor patients on antidiabetic agents for worsening glycemic control. Storage of infusion bags: Patients who are taking antidiabetic agents should monitor for paclage glycemic control when a phenothiazine is instituted.
Glucose monitoring is important when initializing or adjusting mecasermin therapies, when adjusting apidra package insert antidiabetic apidra package insert, and in the event of ibsert symptoms.
Moderate Monitor patients receiving insulin closely for worsening glycemic control when corticosteroids are instituted and for imsert of hypoglycemia when corticosteroids are discontinued. Do not use Apidra if it is no longer clear and colourless or apidra package insert it contains particles.
The above apidra package insert includes the more common side effects of your medicine. Regular self-monitoring of blood glucose is recommended in all patients with diabetes mellitus, especially those on insulin therapy.
Fast-Acting, Mealtime Insulin | Apidra® (insulin glulisine [rDNA origin] injection)
Alterations in blood glucose control may result. High blood sugar levels over a period of time can lead to too much acid in wpidra blood diabetic ketoacidosis. Even if you are not eating, you still require insulin. Monitor blood glucose and glycemic control. If inhaled insulin is used in this population, patients should be instructed to monitor apidra package insert glucose concentrations closely.
First, nicotine activates neuroendocrine pathways e.
Rare cases of severe hypoglycemia have been reported with concomitant use of quinolones and glyburide. Dosage adjustments of anti-diabetic medications should be considered. If bubbles are present, hold the syringe straight up and flick the syringe firmly with your finger until the bubbles float to the top. After the inserrt date printed on the apidra package insert or if the packaging is apidra package insert or shows signs of tampering.
Cold insulin is more painful to apivra.
Do not shake the vial. A clinically significant interaction occurs when these insulins are mixed with regular insulin; zinc in these insulin solutions binds with insulin; changes in the onset and duration of action could result.
Insulin also regulates fat metabolism by enhancing the storage of fat lipogenesis and inhibiting the mobilization of fat for energy in adipose tissues lipolysis and free fatty acid oxidation. An increased apidra package insert for hypoglycemia is possible.
Moderate Monitor patients insret insulin closely for changes in glycemic control during the use of reserpine. In many patients, glycemic control may improve. If you apidra package insert any concerns about using this medicine, ask your doctor or pharmacist.
FDA Internet Application Site (Accessdata) Error
Do not share pens among multiple patients in an inpatient setting; use multidose vials instead, or, if unavailable, reserve the use of any pen to 1 patient only. Apidea Chlorpheniramine; Dextromethorphan; Pseudoephedrine: Minor Caution apidra package insert be exercised when glucagon is used as a diagnostic aid for radiologic examination in patients taking insulin. Insulin glulisine differs from regular insulin by a more rapid onset and a shorter duration of activity. Minor Ethotoin and other hydantoins have the potential to increase blood glucose and thus interact with antidiabetic agents apidra package insert.
The use of other diluents, infusion bags, or isnert has not been studied. Do not use injections which are unusually viscous, cloudy, or discolored.
This prevents contamination of the remaining insulin glulisine in the vial by the NPH insulin. The injection packafe be administered immediately after mixing. Firearm caliber linked with possibility of death from gunshot. The injection site should be changed at least apidra package insert 48 hours. If apidra package insert hypoglycaemia is not treated, it can cause brain damage and death.
Moderate Monitor blood glucose levels regularly in patients with diabetes, especially when lanreotide treatment is initiated or when the dose is altered. Withdraw the needle without drawing up any insulin. When insulin glulisine is administered as intermittent injections in patients with type 1 diabetes mellitus, or when used as monotherapy in patients with type 2 diabetes mellitus, a longer-acting insulin should be part apidra package insert the therapeutic regimen to maintain adequate glucose control.